On September 28 uniMIND Central Session will host Mauro Cavarra for an open discussion on our recently published paper reviewing the different models of psychedelic-assisted psychotherapy used in clinical trials. The session will start at 7pm (CEST) and anyone is welcome to join via the MIND Community Platform.
Do psychedelics work for chronic pain? We asked the patients themselves! In our recent article we present the results of a survey study addressed to chronic pain sufferers who are using psychedelics (both in full doses and in microdoses) to seek relief. Our results support the hypothesis that both dosing regimens hold promise for chronic… Continue reading Analgesic potential of psychedelics in chronic pain sufferers: a population survey
Dr. Kim Kuypers will be speaking at the Annual Scientific Meeting & Clinical Lab Expo 2022 in Chicago on Monday July 25. Her talk will focus on the effects of psychedelics in full hallucinogenic doses and microdoses on human cognitive performance, empathy and wellbeing: implications for therapeutic applications. The session will consist of three speakers… Continue reading Annual Scientific Meeting & Clinical Lab Expo 2022
Curious about the history and current state of psychedelic research in the Netherlands? Prof Jan Ramaekers gives an overview at our most recent symposium. https://www.youtube.com/watch?v=K1EUyp7Zn-g&list=PL_BEhasNvGp86FDLoWvOh01YxcYnLlWT6&index=1
What do we mean when we say Psychedelic-Assisted Psychotherapy (PAP)? While some general guidelines to conduct PAP treatment programs are quite established and agreed upon, the degree of variability within the preparation - drug session - integration model is still very high. Our latest publication collects, compares and analyses the different therapeutic approaches that are… Continue reading Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
